✦ LIBER ✦

Efficacy of caspofungin in invasive candidiasis and candidemia – de-escalation strategy

✍ Scribed by C. Lichtenstern; T. H. Nguyen; P. Schemmer; T. Hoppe-Tichy; M. A. Weigand

Book ID: 108914556
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 106 KB
Volume: 51
Category: Article
ISSN: 0933-7407
DOI: 10.1111/j.1439-0507.2008.01527.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacies of caspofungin and a combinat

Efficacies of caspofungin and a combination of caspofungin and meropenem in the treatment of murine disseminated candidiasis

✍ SEMA KECELI OZCAN; FATMA BUDAK; AYSE WILLKE; SERDAR FILIZ; PELIN COSTUR; HAKKI D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

Efficacy of caspofungin against invasive

Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients

✍ Robert Betts; Axel Glasmacher; Johan Maertens; Georg Maschmeyer; Jose A. Vazquez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Management of invasive candidiasis and c

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment

✍ Benoît P. Guery; Maiken C. Arendrup; Georg Auzinger; Élie Azoulay; Márcio Borges 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 235 KB

Management of invasive candidiasis and c

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis

✍ Benoît P. Guery; Maiken C. Arendrup; Georg Auzinger; Élie Azoulay; Márcio Borges 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 232 KB

Efficacy and safety of caspofungin thera

Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infections

✍ M. J. DiNubile; K. M. Strohmaier; R. J. Lupinacci; A. R. Meibohm; C. A. Sable; N 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 130 KB

The changing epidemiology of invasive ca

The changing epidemiology of invasive candidiasis : Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy

✍ Ray Hachem; Hend Hanna; Dimitrios Kontoyiannis; Ying Jiang; Issam Raad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract ## BACKGROUND. The objective of the current retrospective study was to compare the epidemiology of candidemia and its risk factors in patients who had hematologic malignancies(HM) with those in patients who had solid tumors (ST). ## METHODS. The medical and electronic records of all